636 related articles for article (PubMed ID: 2471770)
81. Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigens.
Farina C; van der Bruggen P; Boël P; Parmiani G; Sensi M
Int Immunol; 1996 Sep; 8(9):1463-6. PubMed ID: 8921424
[TBL] [Abstract][Full Text] [Related]
82. Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung.
Echchakir H; Vergnon I; Dorothée G; Grunenwald D; Chouaib S; Mami-Chouaib F
Int Immunol; 2000 Apr; 12(4):537-46. PubMed ID: 10744655
[TBL] [Abstract][Full Text] [Related]
83. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions.
Anichini A; Molla A; Mortarini R; Tragni G; Bersani I; Di Nicola M; Gianni AM; Pilotti S; Dunbar R; Cerundolo V; Parmiani G
J Exp Med; 1999 Sep; 190(5):651-67. PubMed ID: 10477550
[TBL] [Abstract][Full Text] [Related]
84. Cytotoxic T cell clones against human autologous cancers: analysis of target antigen and the mechanism of specific target cell destruction.
Kikuchi K; Okubo M; Sato T; Sato N
Princess Takamatsu Symp; 1988; 19():303-13. PubMed ID: 3269362
[TBL] [Abstract][Full Text] [Related]
85. Role of MHC class-I antigens and the CD3 complex in the lysis of autologous human tumours by T-cell clones.
Roberts TE; Shipton U; Moore M
Int J Cancer; 1987 Apr; 39(4):436-41. PubMed ID: 3104214
[TBL] [Abstract][Full Text] [Related]
86. Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.
Gottlieb DJ; Li YC; Lionello I; Tanzarella S; Marangolo M; Bradstock KF; Russo V; Traversari C
Br J Cancer; 2006 Jul; 95(2):181-8. PubMed ID: 16819544
[TBL] [Abstract][Full Text] [Related]
87. T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis.
Anichini A; Mortarini R; Alberti S; Mantovani A; Parmiani G
Int J Cancer; 1993 Apr; 53(6):994-1001. PubMed ID: 8097188
[TBL] [Abstract][Full Text] [Related]
88. Differential modulation by interferon gamma of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigens.
Kirkin AF; thor Straten P; Zeuthen J
Cancer Immunol Immunother; 1996 May; 42(4):203-12. PubMed ID: 8665567
[TBL] [Abstract][Full Text] [Related]
89. Distribution of autologous tumor-specific cytotoxic T lymphocytes in human metastatic melanoma.
Itoh K; Salmeron MA; Morita T; Seito D; Mansfield PF; Ross MI; Balch CM; Augustus LB
Int J Cancer; 1992 Aug; 52(1):52-9. PubMed ID: 1500228
[TBL] [Abstract][Full Text] [Related]
90. Functional and phenotypic properties of peripheral T cells anergized by autologous CD3(+) depleted bone marrow cells.
Jin Y; Fuller L; Carreno M; Esquenazi V; Blomberg BB; Wei YT; Ciancio G; Burke GW; Tzakis A; Ricordi C; Miller J
Hum Immunol; 2002 Jul; 63(7):567-75. PubMed ID: 12072192
[TBL] [Abstract][Full Text] [Related]
91. Helper cell-independent cytotoxic clones in man.
Wee SL; Chen LK; Strassmann G; Bach FH
J Exp Med; 1982 Dec; 156(6):1854-9. PubMed ID: 6217275
[TBL] [Abstract][Full Text] [Related]
92. Presence on a human melanoma of multiple antigens recognized by autologous CTL.
Van den Eynde B; Hainaut P; Hérin M; Knuth A; Lemoine C; Weynants P; van der Bruggen P; Fauchet R; Boon T
Int J Cancer; 1989 Oct; 44(4):634-40. PubMed ID: 2529220
[TBL] [Abstract][Full Text] [Related]
93. Establishment of stable CD8+ suppressor T cell clones and the analysis of their suppressive function.
Hu FY; Asano Y; Sano K; Inoue T; Furutani-Seiki M; Tada T
J Immunol Methods; 1992 Jul; 152(1):123-34. PubMed ID: 1386378
[TBL] [Abstract][Full Text] [Related]
94. Peripheral blood and tumor infiltrating lymphocytes in non-small cell lung cancer: analysis at the population and clonal level.
Viale M; Ferrini S; Serrano S; Serrano D; Ardizzoni A; Nicolin A
Tumori; 1990 Oct; 76(5):488-94. PubMed ID: 2175060
[TBL] [Abstract][Full Text] [Related]
95. Two distinct mechanisms of cytotoxicity mediated by herpes simplex virus-specific CD4+ human cytotoxic T cell clones.
Yasukawa M; Yakushijin Y; Fujita S
Clin Immunol Immunopathol; 1996 Jan; 78(1):70-6. PubMed ID: 8599887
[TBL] [Abstract][Full Text] [Related]
96. Melanoma cell lysis by human CTL clones: differential involvement of T3, T8 and HLA antigens.
Fossati G; Anichini A; Parmiani G
Int J Cancer; 1987 Jun; 39(6):689-94. PubMed ID: 3108167
[TBL] [Abstract][Full Text] [Related]
97. Augmentation of interleukin-2-induced activation of human melanoma tumor-infiltrating lymphocytes by heteroconjugate antibody.
Mansfield PF; Rosenblum MG; Murray JL; Itoh K
Cancer Immunol Immunother; 1991; 33(4):247-54. PubMed ID: 1829394
[TBL] [Abstract][Full Text] [Related]
98. Membrane structures involved in auto-tumor recognition.
Vánky F
Biochim Biophys Acta; 1986 Dec; 865(3):253-65. PubMed ID: 3539197
[TBL] [Abstract][Full Text] [Related]
99. Induction of CD4+ cytotoxic T cells by sensitization with allogeneic melanomas bearing shared or cross-reactive HLA-A.
Hayashi Y; Hoon DS; Park MS; Terasaki PI; Foshag LJ; Morton DL
Cell Immunol; 1992 Feb; 139(2):411-25. PubMed ID: 1733512
[TBL] [Abstract][Full Text] [Related]
100. Production of stable cytolytic T-cell clones directed against autologous human melanoma.
Hérin M; Lemoine C; Weynants P; Vessière F; Van Pel A; Knuth A; Devos R; Boon T
Int J Cancer; 1987 Mar; 39(3):390-6. PubMed ID: 3493226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
